Skip to main navigation
Cartesian Therapeutics, Inc
  • About Us
    • Leadership
    • Board of Directors
    • Advisors
  • Science
    • mRNA Cell Therapy
    • Proprietary Platform
    • Manufacturing
    • Publications & Presentations
  • Pipeline
    • Descartes-08
    • Descartes-15
  • Patients
    • Clinical Trials
    • Patient Resources
  • Careers
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Investor Resources

SEC Filing Details

Financial Information
  • SEC Filings
  • Annual Reports

Document Details

Form
D/A
Filing Date
December 4, 2023
Document Date
December 4, 2023
Filing Group
Other
Company
Cartesian Therapeutics, Inc
Issuer
CARTESIAN THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • About Us
  • Science
  • Pipeline
  • Patients
  • Careers
  • Investors
  • Go to linkedin page
  • Go to Twitter page

7495 New Horizon Way, Frederick, MD 21703

info@cartesiantx.com

  • Global Privacy Notice
  • HCP Privacy Notice
  • Vendor Privacy Notice
  • Terms of Service
  • FCOI Policy
  • Expanded Access Policy
Cartesian Therapeutics, Inc

©2026 Cartesian Therapeutics, Inc. All Rights Reserved.